1. 1340. Population Pharmacokinetic (PK) Analysis of APX001 Using Phase 1 Data. (26th November 2018) Authors: Trang, Michael; Bader, Justin C; Ople, Eric A; Kramer, William G; Hodges, Michael R; Bhavnani, Sujata M; Rubino, Christopher M Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Meropenem–Vaborbactam Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses as Support for Dose Selection in Patients with Normal Renal Function and Varying Degrees of Renal Impairment. (4th October 2017) Authors: Bhavnani, Sujata M; Trang, Michael; Griffith, David C; Lomovskaya, Olga; Hammel, Jeffrey P; Loutit, Jeffrey S; Dudley, Michael N; Ambrose, Paul G; Rubino, Christopher M Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S530 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Population Pharmacokinetic (PPK) Analysis of ZTI-01 (Fosfomycin for Injection) Using Data from Healthy Subjects and Patients with Complicated Urinary Tract Infections (cUTI). (4th October 2017) Authors: Trang, Michael; Ellis-Grosse, Evelyn J; Eckburg, Paul B; Skarinsky, David; Bhavnani, Sujata M; Rubino, Christopher M Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S529 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Use of Monte Carlo simulation and considerations for PK-PD targets to support antibacterial dose selection. (October 2017) Authors: Trang, Michael; Dudley, Michael N; Bhavnani, Sujata M Journal: Current opinion in pharmacology Issue: Volume 36(2017) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗